Clinical trial
A Clinical Study to Evaluate the Safety and Efficacy of the CryoCor(TM)Cardiac Cryoablation System for the Treatment of Paroxysmal Atrial Fibrillation
NCT00231296 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Evaluate the Safety and Efficacy of the CryoCor(TM)Cardiac Cryoablation System for the Treatment of Paroxysmal Atrial Fibrillation
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- March 31, 2009
- Enrollment
- 174 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.